tirzepatide increased libido Tirzepatide Reduces Food Intake and

Retatrutide (also known by its development code, LY3437943) isn't just another GLP-1 receptor agonist

Among more than 17,000 patients with preexisting cardiovascular disease, who are overweight or obese and do not have diabetes, those who took semaglutide showed a 20 percent reduction in major adverse cardiovascular events and nonfatal strokes

Interest in the relationship between GLP-1 medications and eye health increased after researchers published a study in JAMA Ophthalmology that found a possible association between semaglutide use and NAION

Mental Wellness and Transformation: GLP-1 and Mental Health The journey to better health profoundly impacts mental health

Missed Zepbound by more than 4 days: skip that dose entirely